RDRC/SHUR Committees

The Radioactive Drug Research Committee (RDRC) and the Subcommittee on the Human Use of Radioisotopes (SHUR) are subcommittees under the U-M Radiation Policy Committee.  These subcommittees oversee research protocols involving radiopharmaceuticals and human subjects.   Following the RCRC/SHUR reviews are complete, the protocol is submitted to the Institutional Review Board (IRB) MED for approval.



Radiation Risk Language

IRB-MED Approval for RDRC/SHUR Approved Protocols

Amending an RDRC/SHUR Previously-Approved Protocol

Skip to content